← FDATracker
HomeAdverse Events

ENBREL Adverse Event: Lung neoplasm malignant

ENBREL Adverse Event: Lung neoplasm malignant is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: ENBREL; Product category: Drug; Primary reaction: Lung neoplasm malignant.

Primary drugENBREL
Product categoryDrug
Primary reactionLung neoplasm malignant
All reactionsLung neoplasm malignant
SeriousnessSerious
Patient outcomeFatal
Patient sexFemale
All drugs reportedENBREL
Reporter countryUS
Reporter type5
Report date20140313
Report ID10005856

🔍 Search all adverse events →